ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 71 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2018. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $82,414 | +146.7% | 40,598 | +179.5% | 0.00% | – |
| Q2 2023 | $33,403 | -47.3% | 14,523 | -30.6% | 0.00% | – |
| Q1 2023 | $63,433 | +19.7% | 20,935 | -8.0% | 0.00% | – |
| Q4 2022 | $53,014 | +20.5% | 22,753 | -0.3% | 0.00% | – |
| Q3 2022 | $44,000 | -17.0% | 22,822 | +17.5% | 0.00% | – |
| Q2 2022 | $53,000 | -8.6% | 19,430 | +2.1% | 0.00% | – |
| Q2 2021 | $58,000 | -42.6% | 19,036 | -32.3% | 0.00% | – |
| Q1 2019 | $101,000 | -78.3% | 28,128 | -76.9% | 0.00% | -100.0% |
| Q4 2018 | $466,000 | +5.9% | 121,642 | +161.2% | 0.00% | – |
| Q3 2018 | $440,000 | +214.3% | 46,576 | +142.3% | 0.00% | – |
| Q2 2018 | $140,000 | – | 19,222 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Two Seas Capital LP | 825,569 | $3,211,000 | 2.46% |
| GREAT POINT PARTNERS LLC | 668,907 | $2,602,000 | 0.58% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 270,000 | $1,050,000 | 0.47% |
| QCM Cayman, Ltd. | 10,205 | $40,000 | 0.24% |
| Pitti Group Wealth Management, LLC | 50,000 | $195,000 | 0.22% |
| RTW INVESTMENTS, LP | 2,504,493 | $9,742,000 | 0.14% |
| Hudson Bay Capital Management LP | 1,805,700 | $7,024,000 | 0.07% |
| Quinn Opportunity Partners LLC | 276,485 | $1,076,000 | 0.07% |
| Kepos Capital LP | 200,000 | $778,000 | 0.06% |
| XTX Topco Ltd | 29,026 | $113,000 | 0.06% |